[HTML][HTML] Pharmacological interventions for treating dyslipidemia in patients with HIV infection

AJ Martí‐Carvajal, M Cruciani - The Cochrane Database of …, 2018 - ncbi.nlm.nih.gov
Background With the advent of highly active antiretroviral therapy (HAART)(Appendix 1), the
clinical course of Human Immunodeficiency Virus (HIV) infection has been transformed from …

Human immunodeficiency virus as a chronic disease: evaluation and management of nonacquired immune deficiency syndrome-defining conditions

S Serrano-Villar, F Gutiérrez, C Miralles… - Open Forum …, 2016 - academic.oup.com
In the modern antiretroviral therapy (ART) era, motivated people living with human
immunodeficiency virus (HIV) who have access to therapy are expected to maintain viral …

[引用][C] HIV-1 update 2018

BJ Dong - Pharmacy Today, 2018 - Elsevier

The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care

K Samaras - Current HIV/AIDS Reports, 2012 - Springer
Abstract Treatment of HIV infection with highly active antiretroviral therapy (HAART) confers
survival and quality of life benefits. However, these significant benefits are at the cost of …

A review of management of inflammation in the HIV population

J Slim, CF Saling - BioMed research international, 2016 - Wiley Online Library
Advancements in antiretroviral therapy have drastically increased the life expectancy for
those infected with HIV. Today, a new subgroup of older patients with long‐term controlled …

Management of metabolic complications of therapy

J Currier - Aids, 2002 - journals.lww.com
The major metabolic abnormalities that complicate the management of HIV infection include
dyslipidemia, morphologic changes (fat accumulation and lipoatrophy) and dysregulation of …

Antiretroviral therapy: a primer for dermatologists

HN Kim, RD Harrington - Dermatologic clinics, 2006 - derm.theclinics.com
Combination antiretroviral therapy (ART) has transformed the care of individuals with HIV
infection. Effective ART has resulted in dramatic reductions in mortality, hospitalization rates …

[引用][C] A regimen's safety profile should support aging with HIV

R Evaluated, A Treat - helpstoptheviruspro.com
Safety and Tolerability | Help Stop The Virus Pro Skip to content Help Stop the Virus logo. STAY
INFORMED Menu Visit Patient Site Stay Informed Home Comprehensive Approach Treatment …

[PDF][PDF] Chronic Lung Disease in HIV Patients.

S Neri, J Leung, G Besutti, A Santoro, LM Fabbri… - AIDS …, 2018 - researchgate.net
This narrative review discusses literature on chronic obstructive pulmonary disease (COPD)
in people living with HIV (PLWH). Existing data indicate that HIV itself, independent of …

[PDF][PDF] Management of metabolic complications and cardiovascular risk in HIV-infected patients

F Blanco, J San Román, E Vispo, M Lopez, A Salto… - AIDS Rev, 2010 - academia.edu
As result of the great benefit of HAART, AIDS-related deaths have dramatically declined
during the last decade in HIV-infected individuals. However, mortality due to non-AIDS …